集群随机试验中的受限平均存活时间:改进从伪值回归中对干预效应的差异估计
Floriane Le Vilain-Abraham1,2, Solène Desmée1, Jennifer A Thompson3
1Univ Tours, Nantes Université, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Tours, France.
Statistical methods in medical research
|January 12, 2026
概括
本研究引入了改进的统计方法,用于分析集群随机试验 (CRT) 中的受限制平均生存时间 (RMST),集群少于50个. 建议的方法确保准确的干预效应估计和适当的I型错误控制在生存数据分析.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 流行病学 流行病学
背景情况:
- 限制平均存活时间 (RMST) 量化了时间到事件试验中的干预效应.
- 集群随机试验 (CRT) 需要考虑集群内相关性.
- 在CRT中估计ΔRMST的先前方法已在≥50个集群中得到验证.
研究的目的:
- 开发和评估用于在CRT中估计ΔRMST的统计方法,其集群数量很少 (<50).
- 评估一般化估计方程 (GEE) 偏差校正方法的差异估计器.
- 为了比较GEE Wald测试的正常与学生t分布的性能.
主要方法:
- 模拟研究是根据比例和非比例危险假设进行的.
- 评估了GEE三明治差异估计器的四种偏差校正方法.
- 对比了Wald测试统计数据的正常和学生t分布的表现.
主要成果:
- 与正常分布相比,Student t-分布显示出对I型错误率的优越控制.
- 费伊和格劳巴德偏差校正的差异估计器在所有集群号中保持了适当的I型错误率.
- 建议使用GEE进行伪值回归,并结合Fay和Graubard校正和Student t分布.
结论:
- 提出的方法提供了可靠的估计干预效应在CRT的少数集群.
- 在CRT中推使用Fay和Graubard差异估计器和Student t分布进行伪值回归.
- 这些方法在具有挑战性的试验设计中增强了对生存数据的分析,正如DEMETER试验所示.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Survival Tree
382
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
382
Censoring Survival Data
518
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
518
Survival Curves
642
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
642
Kaplan-Meier Approach
556
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
556


